140 related articles for article (PubMed ID: 10874582)
21. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids.
Citver AS; Shields AM; Ciaccia LM; Schulingkamp RJ; Raffa RB
J Clin Pharm Ther; 2002 Jun; 27(3):161-8. PubMed ID: 12081629
[TBL] [Abstract][Full Text] [Related]
22. Current and novel approaches to the drug treatment of schizophrenia.
Rowley M; Bristow LJ; Hutson PH
J Med Chem; 2001 Feb; 44(4):477-501. PubMed ID: 11170639
[No Abstract] [Full Text] [Related]
23. Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist.
Bristow LJ; Kramer MS; Kulagowski J; Patel S; Ragan CI; Seabrook GR
Trends Pharmacol Sci; 1997 Jun; 18(6):186-8. PubMed ID: 9226994
[TBL] [Abstract][Full Text] [Related]
24. Schizophrenia: D4 receptor elevation. What does it mean?
Seeman MV
J Psychiatry Neurosci; 1994 May; 19(3):171-6. PubMed ID: 7913338
[No Abstract] [Full Text] [Related]
25. Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia.
Jardemark K; Wadenberg ML; Grillner P; Svensson TH
Curr Opin Investig Drugs; 2002 Jan; 3(1):101-5. PubMed ID: 12054059
[TBL] [Abstract][Full Text] [Related]
26. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study.
Lahti RA; Roberts RC; Cochrane EV; Primus RJ; Gallager DW; Conley RR; Tamminga CA
Mol Psychiatry; 1998 Nov; 3(6):528-33. PubMed ID: 9857979
[TBL] [Abstract][Full Text] [Related]
27. Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants.
Jovanovic V; Guan HC; Van Tol HH
Pharmacogenetics; 1999 Oct; 9(5):561-8. PubMed ID: 10591536
[TBL] [Abstract][Full Text] [Related]
28. [The involvement of D-1 and D-2 dopamine receptors in the effects of neuroleptics and the pathogenesis of schizophrenia].
Wielgosz M
Psychiatr Pol; 1992; 26(5):357-64. PubMed ID: 1363827
[TBL] [Abstract][Full Text] [Related]
29. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
30. Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions.
Schwartz JC; Diaz J; Pilon C; Sokoloff P
Brain Res Brain Res Rev; 2000 Mar; 31(2-3):277-87. PubMed ID: 10719154
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
Lidow MS; Goldman-Rakic PS
J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
[TBL] [Abstract][Full Text] [Related]
32. The dopamine D4 receptor.
Van Tol HH
NIDA Res Monogr; 1996; 161():20-38. PubMed ID: 8784842
[No Abstract] [Full Text] [Related]
33. Role of dopamine D2, D4 and serotonin(2A) receptors in antipsychotic and anticataleptic action.
Seeman P; Tallerico T; Corbett R; Van Tol HH; Kamboj RK
J Psychopharmacol; 1997; 11(1):15-7. PubMed ID: 9097885
[No Abstract] [Full Text] [Related]
34. Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride.
Seeman P; Guan HC; Van Tol HH
Eur J Pharmacol; 1995 Nov; 286(2):R3-5. PubMed ID: 8605946
[TBL] [Abstract][Full Text] [Related]
35. Expression and characterization of a dopamine D4R variant associated with delusional disorder.
Zenner MT; Nobile M; Henningsen R; Smeraldi E; Civelli O; Hartman DS; Catalano M
FEBS Lett; 1998 Jan; 422(2):146-50. PubMed ID: 9489994
[TBL] [Abstract][Full Text] [Related]
36. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Kapur S; Remington G
Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the D4 dopamine receptor gene variant in an Italian schizophrenia kindred.
Macciardi F; Petronis A; Van Tol HH; Marino C; Cavallini MC; Smeraldi E; Kennedy JL
Arch Gen Psychiatry; 1994 Apr; 51(4):288-93. PubMed ID: 7909222
[TBL] [Abstract][Full Text] [Related]
38. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of D2- and D4-blocking neuroleptics on the procedural learning of schizophrenic patients.
Bédard MA; Scherer H; Delorimier J; Stip E; Lalonde P
Can J Psychiatry; 1996 Sep; 41(7 Suppl 1):S21-4. PubMed ID: 8884048
[TBL] [Abstract][Full Text] [Related]
40. Influence of the antipsychotic drug pipamperone on the expression of the dopamine D4 receptor.
Van Craenenbroeck K; Gellynck E; Lintermans B; Leysen JE; Van Tol HH; Haegeman G; Vanhoenacker P
Life Sci; 2006 Dec; 80(1):74-81. PubMed ID: 16978659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
